Welcome to our dedicated page for Nasdaq news (Ticker: $NDAQ), a resource for investors and traders seeking the latest updates and insights on Nasdaq stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nasdaq's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nasdaq's position in the market.
The Nasdaq Stock Market announced the delisting of several companies: Better Therapeutics, Tritium DCFC, Arcimoto, Next.e.GO, Acutus Medical, and NeuBase Therapeutics.
These companies had their securities suspended on various dates between March 18, 2024, and May 13, 2024, and have not traded since their respective suspension dates. This action underscores the importance of adhering to Nasdaq's listing requirements.
For more detailed information, Nasdaq’s rules on delisting can be accessed on their official website.
On May 15, 2024, Nasdaq (NDAQ) announced a new AI-powered feature for its Market Surveillance technology, aimed at enhancing market abuse investigations. This generative AI feature, developed using Amazon Bedrock, will improve the quality, speed, and efficiency of these investigations, reducing investigation time by 33%. The technology consolidates and analyzes data, aiding analysts in detecting and assessing suspicious activities more effectively. This enhancement is part of Nasdaq's broader AI strategy, which spans multiple business units, including North American Markets Services and Financial Crime Management Technology. The initiative underscores Nasdaq's commitment to maintaining market integrity and leveraging advanced technologies to support global financial systems.
Nasdaq (NDAQ) announced its 2024 Annual Meeting of Shareholders is scheduled for June 11, 2024, at 8:00 AM ET. The virtual meeting can be accessed 15 minutes before the start via www.virtualshareholdermeeting.com/NDAQ2024. Shareholders on record as of April 15, 2024, are eligible to vote and participate. Relevant documents, including the 2024 Proxy Statement and 2023 Annual Report on Form 10-K, are available at www.nasdaq.com/annual-meeting. The Proxy Statement provides details on voting and virtual attendance procedures.
Nasdaq reported short interest data for the month ending April 30, 2024, showing an increase in short interest in Nasdaq Global Market and Nasdaq Capital Market securities compared to the previous reporting period. The total short interest in all Nasdaq securities saw a slight increase, reflecting 2.73 days average daily volume for the reporting period.
Nasdaq (NDAQ) reported monthly volumes for April 2024 on its investor relations website. The data can be found at the provided link.
The Southern California NIRI chapters and Nasdaq are hosting the 2nd Annual NIRI SoCal Conference on May 16th, 2024, in Irvine, CA. The event will focus on key issues in investor relations, finance, and corporate communications, featuring panel discussions with industry experts and opportunities for networking and learning.
The 2nd Annual NIRI SoCal Conference hosted by Southern California NIRI Chapters and Nasdaq will take place on May 16th, 2024, in Irvine, CA. The event will focus on issues relevant to public companies in investor relations, finance, and communications. The conference will feature panel discussions, networking opportunities, and insights from industry experts.
